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Glyceryl monooleate (GMO) is a polar lipid that can exist in various liquid crystalline phases
in the presence of different amounts of water. It is regarded as a permeation enhancer due
to its amphiphilic property. Various phases of GMO/solvent system containing sodium
fluorescein were prepared to compare permeability using confocal laser scanning micro-
scopy (CLSM). GMO was melted in a vial in a water bath heated to 45 C. Propylene glycol
and hexanediol were homogeneously dissolved in the melted GMO. Sodium fluorescein in
aqueous solution was diluted to various ratios and thoroughly mixed by an ultrasonic
homogenizer. Each GMO/Solvent system with fluorescein was applied onto the epidermal
side of excised pig skin and incubated overnight. CLSM was performed to observe how the
GMO/solvent system in its different phases affect skin permeability. Cubic and lamellar
phase formulations enhanced the fluorescein permeation through the stratum corneum. A
solution system had the weakest permeability compared to the other two phases. Due to
the amphiphilic nature of GMO, cubic and lamellar phases might reduce the barrier
function of stratum corneum which was observed by CLSM as fluorescein accumulated in
the dermis. Based on the results, the glyceryl monooleate lyotropic mixtures could be
applied to enhance skin permeation in various topical and transdermal formulations.
© 2014 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Glyceryl monooleate (GMO) is a well-known molecule
commonly used as an emulsifying agent, biocompatibleKang), shjeong@dongguk
g Pharmaceutical Univer
University. Production ancontrolled-release material, and a food additive. It is consid-
ered as a nontoxic, biodegradable, and biocompatiblematerial
classified as “generally recognized as safe” (GRAS). It is
included in the FDA Inactive Ingredients Guide and present in
nonparenteral medicines in the United Kingdom [1]..edu (S.H. Jeong).
sity.
d hosting by Elsevier B.V. All rights reserved.
a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 3 2 4e3 2 9 325GMO is a polar lipid with the ability to form various liquid
crystalline phases in the presence of different amounts of
water. In the presence of a small amount of water, GMO
forms reversed micelles characterized by an oily texture. As
more water is added, a mucous-like system is formed that
corresponds to the lamellar phase. A large isotropic phase
region dominates when more water is added (20 ~ 40%). This
phase, known as the cubic phase, is highly viscous. In
addition, the temperature and ratio of weight to water plays
a role in the various phases of GMO. In the presence of high
amounts of water in temperatures ranging from 20 ~ 70 C,
the cubic phase might exist in a stable condition [2]. The
cubic phase is said to be bicontinuous since it consists of a
curved bilayer extending in three dimensions, separating
two congruent water channel networks. The water pore
diameter is about 5 nm when the cubic phase is fully
swollen. The presence of a lipid and an aqueous domain
gives special properties to the cubic phase such as the ability
to solubilize hydrophilic, hydrophobic, and amphiphilic
substances [3].
Previous research has demonstrated that the liquid crys-
talline phases of GMO such as the cubic and reversed hexag-
onal phase, increased transdermal drug delivery [4]. The
advantages of the formulations for transdermal drug delivery
system might include biocompatibility and the ability to self-
assemble their structure. The cubic phase of GMO can be
dispersed in a water-rich environment and form a dispersion
containing nanometer-sized particles. GMO's interaction with
phospholipid bilayers might suggest why it is known as a
permeation enhancer [5].
In the current study, effects of various formulations of
GMO/water system on skin permeability were evaluated using
Franz-diffusion cells and confocal laser scanning microscopy
(CLSM). To test the permeability of each formulation, sodium
fluorescein was added to the mixture that was applied on
excised pig skin. Even though the influence of GMO on the
percutaneous absorption through hairless mouse skin has
been studied [6], differences between the GMO/water formu-
lations and how they affect permeability and distribution
throughout the layers of the skin have not been investigated.
This study might provide an insight to understand the effects
of formulation on the skin permeation.Table 1 e Compositions of cubic, lamellar, and solution
formulations for the current study.
Component Cubic phase Lamellar phase Solution
Water 0.199 0.119 0.969
Glyceryl monooleate 0.650 0.850 e
Propylene glycol 0.120 e e
Hexanediol 0.030 0.030 0.030
Sodium fluorescein 0.001 0.001 0.0012. Material and methods
2.1. Materials
Glyceryl monooleate (GMO), propylene glycol, hexanediol,
paraformaldehyde, sodium chloride, potassium chloride, po-
tassium phosphate monobasic, potassium phosphate dibasic,
and sodium fluorescein were purchased from SigmaeAldrich
Co. (St. Louis, MO, USA). Excised pig skin obtained from PWG
Genetics Korea, Ltd. (Pyeongtaek, Gyeonggi, Korea). FSC 22
Frozen section media was purchased from Leica Biosystems
(Wetzlar, Hesse, Germany). Hydrophobic PTFEmembranewas
purchased from Pall Corporation (New York, NY, USA). Hy-
drophilic nitrocellulose membrane was purchased from EMD
Millipore (Billerica, MA, USA).2.2. Preparation of formulations
Three different formulations were prepared for the current
study (Table 1). Lyotropic liquid crystalline phases (cubic and
lamellar phases) were produced by melting GMO in a vial at
45 C and then propylene glycol and hexanediol were dis-
solved in the melted GMO. Propylene glycol was utilized in
order to slow down the drastic increase of viscosity during the
cubic phase formation by mixing GMO and water. A small
amount of hexanediol was added to prevent bacterial growth
in themixture and prolong the shelf-life. An aqueous solution
of fluorescein was produced by dissolving hexanediol and
sodium fluorescein in deionized water. The aqueous solution
of sodium fluorescein was slowly added to the mixture while
it was strongly agitated by an ultrasonic homogenizer to form
lyotropic liquid crystalline phases.2.3. In vitro diffusion studies with membranes
In vitro diffusion study was carried out using Franz-type
diffusion cells assembled with hydrophobic PTFE membrane
and hydrophilic nitrocellulose membrane between the donor
and receptor chambers. The volume of each chamber was
12.5 ml and the diffusion area was 1.82 cm2. Pore size of the
membranes was 0.45 mm. To simulate a skin's lipid-bilayer,
hydrophobic membranes were dipped in melted GMO and
soaked in receptor medium for 30 min before diffusion
studies. After the membranes were soaked, the hydrophobic
membrane was attached to the hydrophilic membrane and
both remained attached during the diffusion experiment.
The receptor chamber was filled with phosphate buffered
saline (pH 7.4). Thedonor chamber containing the cubic phase,
lamellar phase, or solution samples with 1 mg/ml of the so-
dium fluorescein were applied on the upper surface of the
hydrophobic membrane. Receptor components were contin-
uously stirred with a magnetic stirrer and samples were
withdrawn at predetermined time intervals (1, 2, 3, 4, 6, 8, and
12 h). After withdrawing samples from the receptor, the re-
ceptor was replacedwith the same volume of fresh phosphate
buffered saline to maintain sink condition. The content of so-
dium fluorescein was analyzed by multi-mode microplate
reader. The cumulative amount of sodiumfluorescein released









where Q is the cumulative amounts of sodium fluorescein
released per surface area of the membrane (mg/cm2) and Cn
Table 2 e Properties of the sodium fluorescein calibration
curves using confocal microscopy.
Number Range (mg/ml) Slope Intercept R2
1 0.064e32 1702.7617 74.4438 0.9996
2 1690.0246 62.9946 0.9995
3 1696.3530 78.0563 0.9998
Average 1696.3797 71.8316 0.9997
SD 6.3686 7.8633 0.0001
RSD (%) 0.3754 10.9468 0.0109
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determined at nth sampling interval. V is the volume of in-
dividual Franz-type diffusion cell, S is the volume of sam-
pling aliquot (0.5 ml), and A is the surface area of membrane.
The cumulative amounts released per surface area were
plotted against time. The steady-state flux (J) was obtained
from the slope of the linear portion of plotted cumulative
released amounts of compound. The lag time (Tlag) was ob-
tained from the intercept of extrapolated linear portion with
time axis (x-axis). Statistical analysis was performed using
the student's t test and analysis variance (one-way ANOVA,
Dunnett's multiple comparison test of SigmaStat 3.5, Dundas
software, Germany) with a P-value of 0.05 considered to be
significant.
2.4. Fluorescence assay
Fluorescence emission spectra of sodium fluorescein were
obtained using SpectraMax M3 multi-mode microplate reader
(Molecular device, Sunnyvale, CA, USA). Excitation wave-
lengthwas 492 nm and emissionwavelengthwas 515 nmwith
a 4 nm silt width. The spectra of samples were corrected by
subtracting the corresponding buffer spectra. Before obtaining
the fluorescence of diffused sodium fluorescein, linearity of
the calibration curve was obtained by plotting the nominal
concentration of the standard sodium fluorescein (x) versus
the emission spectra intensity (y) in the tested concentration
range. Accuracy and precision were determined by analyzing
samples in triplicate six times on the same day.
2.5. Confocal laser scanning microscopy (CLSM)
Cubic, lamellar, and solution formulations containing 1 mg/
ml of the fluoresceinwere applied onto the pig skin and left for
5 h and 24 h at 37 C. After the treatment, skin samples were
fixed with 4% paraformaldehyde for 24 h. The fixed skin
samples were embedded in frozen section media and frozen
overnight in a deep freezer at 82.7 C. The frozen skin sam-
ples were cross-sectioned into slices 20 mm thick by Leica
CM1520 cryostat for cell nuclei staining. Sections were stained
with 1 mg/ml of 40, 6-diamidino-2-phenylindole (DAPI) for
10 min at 37 C. After washing with PBS, the cross-section of
the skin samples were imaged by LSM 510 microscope (Carl
Zeiss AG, Oberkochen, Baden-Wu¨rttemberg, Germany) with
dual excitation band of DAPI (358 nm) and FITC filter (488 nm).
Fluorescence imaging processing was performed by ZEN 2012
software and Adobe Photoshop.Fig. 1 e In vitro analysis of sodium fluorescein release (mg/
cm2) across the synthetic membrane from (B) cubic phase,
(C) lamellar phase, and (D) solution (n ¼ 3).3. Result and discussion
3.1. In vitro diffusion studies with membranes
To validate the fluorescence assay method, calibration curves
of the sodium fluorescein were plotted and found to be linear
(R2 0.999) in the tested range of 0.064e32 mg/ml (Table 2). The
limit of detection (LOD) and limit of quantification (LOQ) were
0.015 and 0.046 mg/ml, respectively. The accuracy for 0.32, 1.6,
and 32 mg/ml sodium fluorescein standard solutions (n ¼ 3)
was 2.25, 1.77, and 0.28, respectively (expressed as % variationof themean). The precision for 0.32, 1.6, and 32mg/ml sodium
fluorescein standard solutions (n ¼ 3) was 3.03, 2.32, and 0.19,
respectively (expressed as % coefficient of variation).
The diffusion profiles of sodium fluorescein in various
formulations across the synthetic membrane are shown in
Fig. 1. As the cumulative amount of sodium fluorescein
released per unit surface area in the receptor phase was
plotted against time, a linear relationships after a lag timewas
obtained. The diffusion coefficient and flux of each formula-
tionwere calculated from the slope and lag time (Table 3). Flux
of sodium fluorescein across the synthetic membrane in
descending order was the cubic phase (15.11 mg/cm2 h),
lamellar phase (12.45 mg/cm2 h), and solution formulation
(8.23 mg/cm2 h). The cumulative amount of sodium fluorescein
released at 12 h and fluxes of the cubic and lamellar phases
were significantly greater (P < 0.05) than those of the solution
formulation. The cubic and lamellar phases released about 80
and 39 times more, respectively, compared to the solution.
Since sodium fluorescein is hydrophilic and water-soluble,
diffusion through an oil-wetted hydrophobic membrane
may be a limiting factor. Differences in lag time and fluxmight
cause significant differences in the amount of sodium fluo-
rescein released between each GMO/water formulations. In
addition, the hydrophobicity of GMO in each formulationmay
have an effect on the sodium fluorescein's permeability
through oil-wetted hydrophobic membrane. In a study
investigating the effect of permeation enhancers on trans-
dermal delivery, GMO increased the flux across skin for both
hydrophilic and hydrophobic drugs by inducing reversible









amounts after 12 h (mg/cm2)
Cubic phase 15.11 ± 1.30 0.00453 ± 0.00039 3.31 ± 0.33 64.47 ± 3.60
Lamellar phase 11.02 ± 0.37 0.00331 ± 0.00011 4.53 ± 0.15 30.99 ± 3.95
Solution 8.23 ± 0.28 0.00247 ± 0.00008 6.08 ± 0.24 0.80 ± 0.14
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increasing the fluidity of lipids in skin [7].
Even though the lamellar phase has more GMO than the
cubic phase formulation, the cubic phase released a higher
cumulative amount of sodium fluorescein. A reasonable
explanation for this is that propylene glycol enhanced the
release of sodium fluorescein in the cubic phase formulation
by reducing its viscosity which increased membrane perme-
ability. The lamellar phase shifted to the cubic phase as water
content increasing during membrane permeation [8]. The
shift to cubic phase may have increased the viscosity and
therefore decreased its mobility. It is likely that excess
amounts of GMOmight disturb diffusion through amembrane
in lamellar phase. In the presence of propylene glycol, GMO
also forms a liquid sponge phase which has a bicontinuous
lipid water system [9]. Previous research has demonstrated
that the liquid sponge phase had a better diffusion profile than
the cubic phase formulation. Even though cubic phase
formulation might not form the liquid sponge phase during
diffusion in these experiments, an interaction between GMO
and propylene glycol could promote diffusion through the
membranes. Hydration time might be a factor in the differ-
ence in the diffusion rates between the different formulations.
A previous study found that samples hydrated prior to the
experiments released large amounts of drug because hydro-
philic channels were available during the release of the drug
[10]. As the initial water content increased, drug release
increased due to the increased hydrophilic domain which
accounted for the difference in the amount of drug initially
released [11].
3.2. Confocal microscopy imaging
CLSM was used to observe the distribution of fluorescein in
the skin layers after the application of cubic, lamellar, and
solution formulation. Microscopic images of cross-sectionsFig. 2 e CLSM images to evaluate the distribution of the sodium
application: (A) cubic phase, (B) lamellar phase, and (C) solutionperpendicular to the skin allowed us to observe the distribu-
tion pattern of the fluorescein in the deep region of the excised
skin including the stratum corneum (SC), viable epidermis,
and dermis. The diffusion profiles of sodium fluorescein into
the skin was compared after the application of the different
formulations. As shown in Fig. 2, the distribution of sodium
fluorescein in the skin was visualized by CLSM after 5 h of
topical application.
GMO might facilitate the diffusion of sodium fluorescein
through the viable epidermis and dermis. The cubic phasewas
uniformly distributed in the epidermis and dermis (Fig. 2A).
The lamellar phase also showed relatively uniform distribu-
tion in epidermis and dermis with a small amount present in
the SC (Fig. 2B). Most of the sodium fluorescein in the solution
formulation was unable to permeate the SC region (Fig. 2C).
The image of skin that had the solution formulation applied to
it showed a relatively low intensity of fluorescence at the
epidermis and dermal layer, but a very strong intensity on the
SC. These results support the previous results of diffusion
experiment using Franz-type diffusion cells that looked at
flux, lag time, and diffusion coefficient between different
formulations.
Fig. 3 shows the confocal images of the skin after 24 h of
sample application. The cubic and lamellar phase formula-
tions showed much stronger fluorescence in the dermal layer
compared to the solution formulation. Cubic and lamellar
phases showed strong fluorescence in the dermis after 24 h
of application compared to 5 h-images. Solution formulation
also showed stronger fluorescence than its 5 h-image, but it
was localized in the SC layer. This result might suggest that
most of sodium fluorescein in the solution formulation
might not be able to penetrate SC layer. However, with its
low molecular weight sodium fluorescein might be distrib-
uted to the SC region which could not be removed during
washing, and still showed localized fluorescence after 24 h
(Fig. 3C).fluorescein in excised pig skin after 5 h of sample
formulation. Each scale bar indicates 100 mm.
Fig. 3 e CLSM images to evaluate the distribution of the sodium fluorescein in excised pig skin after 24 h of sample
application: (A) cubic phase, (B) lamellar phase, and (C) solution formulation. Each scale bar indicates 100 mm.
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the lipid matrix of the skin and penetrate through the SC [12].
Because adipose tissue and the hypodermis are more hydro-
phobic than other tissues they make up the skin, most GMO
formulations might interact with the tissues and accumulate
in them. Therefore, confocal images of samples treated with
the cubic and lamellar phases showed stronger fluorescence
at hypodermis and adipose tissues than other tissues in skin.
In addition, the cubic and lamellar phases showed some
localization of high intensity fluorescence in dermis and adi-
pose tissues. The solution formulation showed no localization
in the tissues. Differences in localization might be caused by
the presence of GMO in formulation. Lipids such as oleic acid
and GMOhave a polar head and a relatively short hydrophobic
carbon chain that increases membrane permeability by pro-
moting disorder of intercellular lipids [13]. In this study,
intercellular lipid disorder might cause localization of the
sodiumfluorescein in the dermis and adipose tissue. Different
absorption pathways might also cause difference in the
amount of sodium fluorescein diffused between each formu-
lation. Intercellular pathway seems to be predominant
method of transdermal absorption when using the solution
formulation, whereas the intercluster pathway is the most
common method of absorption for the cubic and lamellar
phase formulations [14]. Higher GMO concentrations did not
improve permeability. The intensity of the fluorescence in the
dermis was directly correlated with an increased with the
permeability and not GMO concentration. At 37 C, GMOmight
exist in a cubic phase when the amount of water is greater
than 40% [15]. During the diffusion test, the lamellar phase
might be hydrated by moisture in the skin and converted to
cubic phase. Therefore, viscosity may increase, which de-
creases the mobility of the GMO/solvent mixture.4. Conclusion
This study suggests that GMO is feasible as an absorption
enhancer for topical drugs. Franz-type diffusion test and
CLSM images in excised pig skin showed improved perme-
ability through the hydrophobic-hydrophilic membrane and
excised pig skin. Both cubic and lamellar formulations with
GMO showed higher permeability and diffusion profiles. Bycomparing the diffusion patterns and confocal images, the
cubic phase performed significantly better than the lamellar
formulation. The results suggest that differences of diffu-
sion were caused by ability of the GMO/solvent mixture to
induce lipid disorder in the skin samples. These results
support the hypothesis that GMO induces intercellular lipid
disorder. High GMO/water ratio does not correlate with high
membrane permeability. The cubic phase contained lower
GMO concentration compared to the lamellar phase but had
better membrane permeability. Our study demonstrates
that GMO is an important substance for SC permeation but
the viscosity of this formulation needs to be further inves-
tigated to improve the diffusion efficacy of active
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